Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

342 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data.
Bain S, Druyts E, Balijepalli C, Baxter CA, Currie CJ, Das R, Donnelly R, Khunti K, Langerman H, Leigh P, Siliman G, Thorlund K, Toor K, Vora J, Mills EJ. Bain S, et al. Among authors: Leigh P. Diabetes Obes Metab. 2017 Mar;19(3):329-335. doi: 10.1111/dom.12821. Epub 2016 Dec 23. Diabetes Obes Metab. 2017. PMID: 27862902 Review.
Adherence to Nice Guidance For Initiating Glp-1 Mimetics Among Patients With Type 2 Diabetes In Primary Care In England And Wales - An Evaluation Using The Clinical Practice Research Datalink (Cprd).
Jameson K, D'Oca K, Murray-Thomas T, O'Regan C, Leigh P. Jameson K, et al. Among authors: Leigh P. Value Health. 2014 Nov;17(7):A362. doi: 10.1016/j.jval.2014.08.794. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200745 No abstract available.
Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis.
Swash M, Burke D, Turner MR, Grosskreutz J, Leigh PN, deCarvalho M, Kiernan MC. Swash M, et al. Among authors: Leigh PN. J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):227-234. doi: 10.1136/jnnp-2019-321938. J Neurol Neurosurg Psychiatry. 2020. PMID: 32054724 No abstract available.
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
Jabbari E, Holland N, Chelban V, Jones PS, Lamb R, Rawlinson C, Guo T, Costantini AA, Tan MMX, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Holton JL, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Williams NM, Grosset DG, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Woodside J, Houlden H, Rowe JB, Morris HR. Jabbari E, et al. Among authors: Leigh PN. JAMA Neurol. 2019 Dec 20;77(3). doi: 10.1001/jamaneurol.2019.4347. Online ahead of print. JAMA Neurol. 2019. PMID: 31860007 Free PMC article.
Corrigendum: An Overview of MicroRNAs as Biomarkers of ALS.
Joilin G, Leigh PN, Newbury SF, Hafezparast M. Joilin G, et al. Among authors: Leigh PN. Front Neurol. 2019 Oct 23;10:1129. doi: 10.3389/fneur.2019.01129. eCollection 2019. Front Neurol. 2019. PMID: 31673251 Free PMC article.
Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial.
Al-Chalabi A, Shaw P, Leigh PN, van den Berg L, Hardiman O, Ludolph A, Aho VV, Sarapohja T, Kuoppamäki M. Al-Chalabi A, et al. Among authors: Leigh PN. J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1165-1170. doi: 10.1136/jnnp-2018-320288. Epub 2019 Jul 17. J Neurol Neurosurg Psychiatry. 2019. PMID: 31315908 Free PMC article.
Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials.
van Eijk RPA, Nikolakopoulos S, Roes KCB, Middelkoop BM, Ferguson TA, Shaw PJ, Leigh PN, Al-Chalabi A, Eijkemans MJC, van den Berg LH. van Eijk RPA, et al. Among authors: Leigh PN. J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1331-1337. doi: 10.1136/jnnp-2019-320998. Epub 2019 Jul 10. J Neurol Neurosurg Psychiatry. 2019. PMID: 31292200 Free PMC article.
Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
Chen Z, Chen JA, Shatunov A, Jones AR, Kravitz SN, Huang AY, Lawrence L, Lowe JK, Lewis CM, Payan CAM, Lieb W, Franke A, Deloukas P, Amouyel P, Tzourio C, Dartigues JF; NNIPPS and BBBIPPS Study Groups, Ludolph A, Bensimon G, Leigh PN, Bronstein JM, Coppola G, Geschwind DH, Al-Chalabi A. Chen Z, et al. Among authors: Leigh PN. Mov Disord. 2019 Jul;34(7):1049-1059. doi: 10.1002/mds.27702. Epub 2019 May 6. Mov Disord. 2019. PMID: 31059154
Predicting the future of ALS: the impact of demographic change and potential new treatments on the prevalence of ALS in the United Kingdom, 2020-2116.
Gowland A, Opie-Martin S, Scott KM, Jones AR, Mehta PR, Batts CJ, Ellis CM, Leigh PN, Shaw CE, Sreedharan J, Al-Chalabi A. Gowland A, et al. Among authors: Leigh PN. Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):264-274. doi: 10.1080/21678421.2019.1587629. Epub 2019 Apr 9. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 30961394 Free PMC article.
342 results
Jump to page